Pablo Lubroth

Pablo Lubroth is an accomplished investor and co-founder with extensive experience in the biotech sector. Currently leading the biotech practice at Hummingbird Ventures since November 2020 and co-founding Decoding Bio in September 2022, Pablo focuses on breakthrough biotech advancements. Previous investment roles include tenure at Future Planet Capital from 2018 to 2020, emphasizing UK biotech incubations and spin-outs, and a brief position as a Corporate Development Associate at Horizon Discovery in 2018, concentrating on gene editing assets and M&A. Early career highlights include co-founding Hera Biotech and conducting research at the University of Cambridge and UCL, exploring drug addiction, obsessive-compulsive disorders, and novel drug targets. Educational qualifications include an MPhil in Bioscience Enterprise and an MSc in Biochemical Engineering from UCL, complemented by a BSc in Pharmacology, Neuroscience from the same institution.